(FILES) In this file photo taken on January 07, 2022, the Moderna Covid-19 vaccine is prepared for administration at Union Station in Los Angeles. – Moderna on June 8, 2022, announced positive results for a new vaccine that targets both the original Covid strain and Omicron. This so-called “bivalent” vaccine was tested in a trial of more 850 adults, who had all received their first three doses of Moderna’s original Spikevax vaccine. (Photo by Frederic J. BROWN / AFP)
